Zobrazeno 1 - 10
of 34
pro vyhledávání: '"B. T. Baune"'
Autor:
G. W. Mattingly, S. J. Mathew, S. V. Parikh, S. T. Aaronson, B. T. Baune, A. Czysz, I. Nandy, V. Ona, C. Brown, S. Kyaga, F. Forrestal, S. Levin, J. Doherty, G. Mattingly
Publikováno v:
European Psychiatry, Vol 67, Pp S327-S328 (2024)
Introduction Zuranolone (ZRN) is a positive allosteric modulator of both synaptic and extrasynaptic gamma-aminobutyric acid type A receptors and a neuroactive steroid approved as an oral, once-daily, 14-day treatment course for adults with postpartum
Externí odkaz:
https://doaj.org/article/e969c03dc5d642a1b50422d649affe13
Publikováno v:
European Psychiatry, Vol 67, Pp S254-S255 (2024)
Introduction Esketamine intranasal spray has been approved in both the USA and EU as a novel treatment in patients with treatment-resistant major depression (TRD) and for the management of acute depressive emergencies during the course of major depre
Externí odkaz:
https://doaj.org/article/1d5418f5d53d42e08a8f68c1ef057b2b
Publikováno v:
European Psychiatry, Vol 67, Pp S704-S704 (2024)
Introduction Patients with difficult-to-treat depression (DTD) need multimodal treatment with combination of psychotherapy, pharmacotherapy and neuromodulation. In severe cases, combination of neuromodulatory techniques may be considered to achieve s
Externí odkaz:
https://doaj.org/article/c3e7425935cd414c9f8a6a79c69176c5
Publikováno v:
European Psychiatry, Vol 67, Pp S585-S586 (2024)
Introduction After the success of polygenic risk scores (PRS) that embed a useful summary of genomic information in a comprehensive score, the wish to develop summary statistics for DNA methylation had become more pressing. Developing such a score fa
Externí odkaz:
https://doaj.org/article/c1aadf81776f43fd9e7fe450614dffca
Publikováno v:
European Psychiatry, Vol 67, Pp S256-S257 (2024)
Introduction Research repeatedly linked inflammation with major depressive disorder (MDD). The presence of an inflammatory subtype of depression is supported by molecular findings as well as imaging reports. We investigated the cell type composition
Externí odkaz:
https://doaj.org/article/d215aa96ce674574a66004f7b704986f
Autor:
A. H. Young, B. T. Baune, N. Cardoner, R. Frey, T. Ito, Y. Kambarov, A. Lacerda, B. Rive, C. von Holt, A. J. Oliveira-Maia
Publikováno v:
European Psychiatry, Vol 67, Pp S363-S365 (2024)
Introduction In ESCAPE-TRD esketamine nasal spray (ESK-NS) significantly increased the probability of achieving remission at Week (Wk) 8 and being relapse‑free through Wk32 after remission at Wk8 versus (vs) quetiapine extended release (Q-XR) in pa
Externí odkaz:
https://doaj.org/article/b258ecf29f364e659e624636dd35b52e
Publikováno v:
European Psychiatry, Vol 67, Pp S703-S704 (2024)
Introduction VNS is a long-term adjunctive treatment option in patients with DTD. It has been shown that patients with VNS as add-on to treatment-as-usual (TAU) have higher response and remission rates than TAU alone. Data on the impact of VNS on the
Externí odkaz:
https://doaj.org/article/bdc00228b4b3456ba21fd42c4b0df3b1
Autor:
E. Kavakbasi, B. T. Baune
Publikováno v:
European Psychiatry, Vol 66, Pp S249-S250 (2023)
Introduction NMDA-Receptor antagonists have rapid antidepressant and antisuicidal properties. However, the antidepressant effect is short lasting raising the question of best maintenance strategy, which is unanswered so far. Invasive vagus nerve stim
Externí odkaz:
https://doaj.org/article/4dae7e77d15c49b19b0bd96d13668140
Autor:
R. Carvalho Silva, C. Hohoff, P. Martini, M. Bortolomasi, R. Bazzanella, V. Menesello, M. Gennarelli, B. T. Baune, A. Minelli
Publikováno v:
European Psychiatry, Vol 66, Pp S115-S116 (2023)
Introduction Early life stress (ELS) associates with unfavourable outcome in Major depressive disorder (MDD) and treatment-resistant depression (TRD). Trauma-focused psychotherapy benefits TRD patients exposed to ELS. Epigenetic processes are altered
Externí odkaz:
https://doaj.org/article/80cc9a19c44f4e118b2aadc92f39ca42
Publikováno v:
Der Nervenarzt. 93:921-930
Zusammenfassung Einführung Seit 20 Jahren ist die Vagusnervstimulation (VNS) eine europaweit zugelassene invasive Therapieoption für therapieresistente Depressionen (TRD). Im Gegensatz zu geläufigeren Behandlungen wie EKT sind Kenntnisse über VNS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e65a4f677cf52ccd886677c52d564a97
https://doi.org/10.1007/s00115-022-01282-6
https://doi.org/10.1007/s00115-022-01282-6